TW200800992A - Imidazo [1,2-a] pyridin-3-yl-acetic acid hydrazides, processes, uses and compositions - Google Patents

Imidazo [1,2-a] pyridin-3-yl-acetic acid hydrazides, processes, uses and compositions

Info

Publication number: TW200800992A
Authority: TW; Taiwan
Prior art keywords: pyridin; acetic acid; imidazo; acid hydrazides; processes
Prior art date: 2006-01-03

Application number

TW095149148A

Other languages

English (en)

Inventor

Jose L Falco

Albert Palomer

Antonio Guglietta

Original Assignee

Ferrer Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-01-03

Filing date

2006-12-27

Publication date

2008-01-01

2006-12-27 Application filed by Ferrer Int filed Critical Ferrer Int

2008-01-01 Publication of TW200800992A publication Critical patent/TW200800992A/zh

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Anesthesiology (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

TW095149148A 2006-01-03 2006-12-27 Imidazo [1,2-a] pyridin-3-yl-acetic acid hydrazides, processes, uses and compositions TW200800992A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP06100030A EP1803722A1 (en)	2006-01-03	2006-01-03	Imidazo[1,2-a]pyridin-3-yl-acetic acid hydrazides, processes for their preparation and pharmaceutical uses thereof

Publications (1)

Publication Number	Publication Date
TW200800992A true TW200800992A (en)	2008-01-01

Family

ID=36691692

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW095149148A TW200800992A (en)	2006-01-03	2006-12-27	Imidazo [1,2-a] pyridin-3-yl-acetic acid hydrazides, processes, uses and compositions

Country Status (22)

Country	Link
US (2)	US7943611B2 (zh)
EP (2)	EP1803722A1 (zh)
JP (1)	JP2009522327A (zh)
KR (1)	KR20080083194A (zh)
CN (1)	CN101395156B (zh)
AR (1)	AR058738A1 (zh)
AT (1)	ATE430748T1 (zh)
AU (1)	AU2006334364B2 (zh)
BR (1)	BRPI0620885A2 (zh)
CA (1)	CA2635802A1 (zh)
DE (1)	DE602006006725D1 (zh)
DK (1)	DK1973907T3 (zh)
ES (1)	ES2327278T3 (zh)
IL (1)	IL192563A0 (zh)
NO (1)	NO20083304L (zh)
PE (1)	PE20071059A1 (zh)
PL (1)	PL1973907T3 (zh)
PT (1)	PT1973907E (zh)
RU (1)	RU2008131798A (zh)
TW (1)	TW200800992A (zh)
UY (1)	UY30066A1 (zh)
WO (1)	WO2007077159A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1845098A1 (en) *	2006-03-29	2007-10-17	Ferrer Internacional, S.A.	Imidazo[1,2-b]pyridazines, their processes of preparation and their use as GABA receptor ligands
CN109053726A (zh) *	2018-09-14	2018-12-21	烟台万润药业有限公司	一种唑吡坦酸的制备方法
KR102349934B1 (ko)	2020-10-19	2022-01-12	신해찬	층간소음방지부재 및 이를 이용한 층간소음방지층 시공방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU532001B2 (en) *	1978-11-20	1983-09-15	Sumitomo Chemical Company, Limited	Polycyclic indole derivatives
FR2492382A1 (fr)	1980-10-22	1982-04-23	Synthelabo	Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
ES2151834B1 (es) *	1998-08-06	2001-08-16	Sint Quimica Sa	Procedimiento para preparar n,n,6-trimetil-2-(4-metilfenil)-imidazo-(1,2-a)-piridina-3-acetamida y sus sales.
US7723324B2 (en) *	2003-10-28	2010-05-25	Sepracor, Inc.	Imidazo[1,2-A]pyridine anxiolytics

2006
- 2006-01-03 EP EP06100030A patent/EP1803722A1/en not_active Withdrawn
- 2006-12-21 DE DE602006006725T patent/DE602006006725D1/de active Active
- 2006-12-21 WO PCT/EP2006/070130 patent/WO2007077159A1/en not_active Ceased
- 2006-12-21 RU RU2008131798/04A patent/RU2008131798A/ru unknown
- 2006-12-21 DK DK06841585T patent/DK1973907T3/da active
- 2006-12-21 PT PT06841585T patent/PT1973907E/pt unknown
- 2006-12-21 ES ES06841585T patent/ES2327278T3/es active Active
- 2006-12-21 EP EP06841585A patent/EP1973907B1/en not_active Not-in-force
- 2006-12-21 KR KR1020087018796A patent/KR20080083194A/ko not_active Ceased
- 2006-12-21 BR BRPI0620885-1A patent/BRPI0620885A2/pt not_active IP Right Cessation
- 2006-12-21 CA CA002635802A patent/CA2635802A1/en not_active Abandoned
- 2006-12-21 US US12/087,423 patent/US7943611B2/en not_active Expired - Fee Related
- 2006-12-21 AT AT06841585T patent/ATE430748T1/de active
- 2006-12-21 PL PL06841585T patent/PL1973907T3/pl unknown
- 2006-12-21 CN CN2006800536332A patent/CN101395156B/zh not_active Expired - Fee Related
- 2006-12-21 AU AU2006334364A patent/AU2006334364B2/en not_active Ceased
- 2006-12-21 JP JP2008548979A patent/JP2009522327A/ja not_active Ceased
- 2006-12-22 PE PE2006001689A patent/PE20071059A1/es not_active Application Discontinuation
- 2006-12-26 UY UY30066A patent/UY30066A1/es unknown
- 2006-12-26 AR ARP060105781A patent/AR058738A1/es not_active Application Discontinuation
- 2006-12-27 TW TW095149148A patent/TW200800992A/zh unknown
2008
- 2008-07-01 IL IL192563A patent/IL192563A0/en unknown
- 2008-07-25 NO NO20083304A patent/NO20083304L/no not_active Application Discontinuation
2011
- 2011-01-24 US US13/012,258 patent/US20110118256A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AR058738A1 (es)	2008-02-20
BRPI0620885A2 (pt)	2011-11-29
PT1973907E (pt)	2009-07-28
CN101395156B (zh)	2011-12-14
US20110118256A1 (en)	2011-05-19
PL1973907T3 (pl)	2009-10-30
US7943611B2 (en)	2011-05-17
CA2635802A1 (en)	2007-07-12
RU2008131798A (ru)	2010-02-10
HK1123792A1 (zh)	2009-06-26
IL192563A0 (en)	2009-02-11
US20090176777A1 (en)	2009-07-09
WO2007077159A1 (en)	2007-07-12
AU2006334364B2 (en)	2011-09-29
ES2327278T3 (es)	2009-10-27
EP1973907B1 (en)	2009-05-06
NO20083304L (no)	2008-09-24
DK1973907T3 (da)	2009-08-24
EP1973907A1 (en)	2008-10-01
CN101395156A (zh)	2009-03-25
AU2006334364A1 (en)	2007-07-12
EP1803722A1 (en)	2007-07-04
PE20071059A1 (es)	2007-10-26
ATE430748T1 (de)	2009-05-15
JP2009522327A (ja)	2009-06-11
KR20080083194A (ko)	2008-09-16
DE602006006725D1 (de)	2009-06-18
UY30066A1 (es)	2007-04-30

Publication	Publication Date	Title
NO20084375L (no)	2008-10-17	Imidazo[1,2-B]pyridaziner, deres fremstilling og deres anvendelse som GABA reseptorligander
MY147442A (en)	2012-12-14	Imidazoquinolines as lipid kinase inhibitors
MX355852B (es)	2018-05-02	Compuestos de pirazolo [3,4-c] piridina y métodos de uso.
PH12012501817A1 (en)	2013-09-02	Polysubstituted derivatives of 6-heteroaryl-imidazo[1,2-a] pyridines, and preparation and therapeutic use thereof
HRP20130614T1 (en)	2013-08-31	Novel pyrazole-substituted arylamides
MY146924A (en)	2012-10-15	Substituted imidazoheterocycles
MA32272B1 (fr)	2011-05-02	Inhibiteurs de raf de pyrazole [3,4-b]pyridine
TW200612956A (en)	2006-05-01	Dihydropteridinones for the treatment of cancer diseases
MX2010006230A (es)	2010-06-23	Derivados de arilamida substituidos con triazol y su uso como antagonistas de receptor purinergico p2x3 y/o p2x2/3.
UY31727A (es)	2009-11-10	Derivados polisustituidos de 2-aril-6-fenil-imidazo[1,2-a]piridinas, su preparación y su aplicación en terapéutica
MY153979A (en)	2015-04-30	Substituted piperidino-dihydrothienopyrimidine
MX2012006962A (es)	2012-07-17	Inhibidores de la esfingosina quinasa.
NO20080393L (no)	2008-03-10	Halogenerte pyrazolo [1,5-A] pyrimidiner, fremgangsmater, anvendelse som GABA-A reseptorligander, sammensetninger og intermediater
RU2009125578A (ru)	2011-01-20	Новые замещенные диазаспиропиридиноновые производные для применения в лечении мсн-1-опосредованных заболеваний
TW200635903A (en)	2006-10-16	Therapeutic agents
EP2310016A4 (en)	2011-09-21	Pde10 inhibitors and related compositions and methods
MX2009013885A (es)	2010-01-27	Derivados de quinolina fusionados utiles como moduladores de acido gamma-aminobutirico.
EA201200863A1 (ru)	2013-01-30	Ингибиторы сфингозинкиназы
TW200604198A (en)	2006-02-01	Substituted diaza-spiro-[4.5]-decane derivatives and their use as neurokinin antagonists
TW200602339A (en)	2006-01-16	Substituted diaza-spiro-[5.5]-undecane derivatives and their use as neurokinin antagonists
TW200730506A (en)	2007-08-16	Compounds and uses thereof
TW200833665A (en)	2008-08-16	1H-quinolin-4-one compounds, processes, uses and compositions
TW200633986A (en)	2006-10-01	Therapeutic agents
NO20072972L (no)	2007-08-23	Terapeutiske pyrazolo[3,4-B]pyridiner og indazoler
MX2011008573A (es)	2011-09-06	5-(2-{[6-(2,2-difluoro-2-feniletoxi)hexil]amino}-1-hidroxietil)-8 -hidroxiquinolin-2(1h)-ona y su uso en el tratamiento de enfermedades pulmonares.